Substance
abuse treatment encompasses a wide array of medicines and approaches for
patients with a habit of abusing psychoactive substances. It can cause
impairment or distress to the individual. The global substance
abuse treatment market report by Market Research
Future (MRFR) contains drivers, challenges, opportunities, and trends for the
forecast period. The impact of the COVID-19 pandemic and its effects have been
included as a catalyst.
Market
Scope
The
global substance abuse treatment market is projected to expand at 11.6% CAGR
over the forecast period. The prevalence of smoking among teenagers can drive
the market demand exponentially. According to the study in the Clinical and
Translational Investigation Journal, more than 60% of individuals start smoking
by the age of 13. Technological advances in diagnostics, rising cases of drug addiction,
and awareness of treatment options can bode well for the global substance abuse
treatment market.
But poor
adherence to treatment and hesitation among individuals for treatment can
hamper market growth.
https://www.marketresearchfuture.com/sample_request/7230
Segmentation
The
global substance abuse treatment market is segmented based on abuse type, treatment
type, and end user.
The
global market for substance abuse treatment, by abuse type is segmented into
drug abuse, alcohol dependence, and tobacco/nicotine addiction. The drug abuse
segment is anticipated to hold the largest market share owing to the increasing
addiction of opioid. According to the National Institute of Drug Abuse, nearly
90 million Americans have died due to opioid abuse.
The
market, by treatment type, is segmented into alcohol addiction treatment,
tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol
addiction treatment segment is further classified into naltrexone, disulfiram,
and acamprosate. The tobacco/nicotine addiction treatment segment is further
classified into nicotine replacement treatment and non-nicotine medication. The
nicotine replacement treatment segment includes nicotine spray, nicotine patch,
nicotine lozenge, nicotine gum, and nicotine inhaler. The non-nicotine
medication segment includes bupropion, and varenicline. The drug abuse
treatment segment is further classified as methadone, buprenorphine, and
naltrexone.
Based on
end user, the market is segmented into inpatient treatment centers, outpatient
treatment centers, and residential treatment centers.
Competitive
Intelligence
INSYS
Therapeutics, Amphastar Pharmaceuticals, Opiant Technologies, Teva
Pharmaceuticals, Mylan Laboratories, Glenmark, Sterinova, Allergan, Sun
Pharmaceuticals, Sanquin, Lupin, Apotex, BioCorRx, Cipla, Forest Laboratories,
Inc., Alkermes Plc, LFB Group, Accord Healthcare, Purdue Pharma LP, Pfizer
Inc., Reckitt Benckiser Pharmaceuticals, Sanofi Aventis, and GlaxoSmithKline
Plc. are key players of the global substance abuse treatment market.
Regional
Analysis
The
Americas dominated the global market for substance abuse treatment owing to
presence of major market players and rising awareness about substance abuse
treatment. In recent years, the launch of campaigns and seminar to spread
awareness about substance abuse and commercials endorsed for treatment by
celebrities can bode well for the regional market. For instance, in February
2017, the Ad Council and Viacom have launched the LISTEN campaign and a new PSA
to address America’s substance abuse crisis.
In 2017,
it was estimated that Europe stood second in the global substance abuse
treatment market. This can be attributed to the rising research and development
investments.
APAC was
projected to be the fastest growing region in 2017. Factors such as increasing
incidence of tobacco addiction, drug addiction, and increasing technological
advancements within the region are boosting the market. According to the
information published in the Frontiers in Psychiatry journal, China is facing
an immense public health challenge from smoking. The number of deaths caused by
cigarette smoking will reach 2 million by 2030 and 3 million by 2050.
On the
other hand, the Middle East and Africa held least share in the global substance
abuse treatment market due to the low per capita income especially within the
African region.
Browse
Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments